Novo Nordisk Beating Lilly in Obesity Pill Market: What It Means for Investors
Novo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
This intro contrasts SP 500 with target date funds, highlighting flexibility, fees, and potential growth paths relevant to retirement planning.
27,405 articlesNovo Nordisk is gaining ground on Lilly in the obesity pill market. This article breaks down the drivers, the competi...
"amazon over 1.56 million" workers sit beside about 1 million robots in Amazon’s sprawling network, signaling a shift...
Oracle's backlog surge and accelerating AI infrastructure growth are fueling a heated debate on whether the stock is ...
AMD posts a 55% month gain as AI data center demand accelerates, eclipsing Intel’s advance. The move sparks a debate ...
A new milestone for Uber signals more than a single quarter of growth. With gross bookings up 25% and a bold autonomo...
A coalition of twelve states filed a federal antitrust suit to block Paramount's $81 billion merger with Warner Bros....
Amazon and Shopify posted contrasting Q1 2026 results, underscoring a widening gap between a capital-heavy expansion ...
A three-way bid for Warner Bros. Discovery produced three market winners, reshaping how investors view streaming, stu...
Duolingo has grown from a buzzy app to a profitable platform. This article explores three plausible paths for the nex...
This article lays out a grounded three-year path for Tesla, focusing on core EV leadership, software-based autonomy r...
Intel is resetting expectations around AI with a focus on edge infrastructure and domestic manufacturing, signaling a...
A timely look at Warren Buffett’s Coca-Cola investment and how Berkshire’s KO stake has powered decades of dividend g...